- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT06014281
Undersøgelse af virkningerne af regelmæssig kort internetbaseret meditationspraksis på mental sundhed og velvære
Et internetadministreret randomiseret kontrolforsøg for at undersøge virkningerne af regelmæssig, kort meditationspraksis på mental sundhed og velvære
The study will examine the effects of online meditation training on stress and anxiety in healthy participants. It will also examine the dose-response relationship between the amount of daily focused attention meditation practice and established mental health outcome measures.
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
This is a 16-week study with an 8-week meditation intervention, with a requirement of a minimum of 10 minutes of meditation practice each day. This study will recruit ~200 healthy subjects (18+ years) with no current or previous diagnosis of psychiatric or neurological disorders who are interested in learning about meditation but don't have long-term experience with meditation. Half of the participant pool will be randomly assigned to the meditation intervention, and the other half will get the wait-list control assignment. The control group will later receive its intervention, likely a few weeks after the completion of the active group's intervention. A focused-attention meditation technique (SOS meditation) will be used to train participants.
Changes in participants' physiological markers (e.g., HRV, physical activity, respiration rate, sleep quality) will be evaluated using passive activity monitoring devices (e.g., Fitbit). Intervention-related changes in mental health will be assessed using web-based mental health and well-being surveys. Improvements in cognitive functioning will be assessed using web-based psychological tasks.
Undersøgelsestype
Tilmelding (Faktiske)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiesteder
-
-
California
-
Stanford, California, Forenede Stater, 94305
- Dept. of Psychiatry, Stanford University
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Age ≥ 18 years
- Able to follow basic instructions for prescreening and scheduling
- Compliant with investigator instructions during the consent process and participation in the study
- Is not already a regular meditation practitioner
Exclusion Criteria:
- Age <18
- People with a current diagnosis of psychiatric or neurological disorders
- Be in current psychiatric treatment or medications
- Hospitalized for psychiatric disorders in the past year or so.
- Regular and long-term meditation practitioners
- Non-English speaking
- Non-USA mailing address to receive the activity tracker device
- Vision or hearing impairment severe enough to interfere with study participation
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: Meditation group
Baseline to week 8: Subjects will be trained to meditate for 10 minutes daily, and several measures (questionnaires, cognitive tests, and physiological measurements) will be obtained to assess the efficacy of daily meditation practice on mental health and well being. Focused-attention meditation technique will be used to train participants. Specifically the SOS meditation technique will be employed. Week 8 to week 16: Subjects will self report if they choose to continue SOS meditation and several measures (questionnaires, cognitive tests, and physiological measurements) will be obtained to assess the impact of continued meditation practice on mental health and well being. |
Focused-attention meditation technique will be used to train participants, specifically the SOS meditation technique. The SOS meditation technique is an easy-to-learn approach where participants are instructed to dissociate their attention from physical awareness, thoughts, and emotions by mentally slowly repeating a calming word or phrase (chosen by the participant themselves). SOS Meditation Instructions:
|
|
Eksperimentel: Waitlist control
Baseline to week 8: Subjects will be place in a control group which receives no intervention. However, several measures (questionnaires, cognitive tests, and physiological measurements) will be obtained to assess baseline mental health and well being scores. Week 8 to week 16: Subjects will be trained to meditate for 10 minutes daily, and several measures (questionnaires, cognitive tests, and physiological measurements) will be obtained to assess the efficacy of daily meditation practice on mental health and well being. Focused-attention meditation technique will be used to train participants. Specifically the SOS meditation technique will be employed. |
Focused-attention meditation technique will be used to train participants, specifically the SOS meditation technique. The SOS meditation technique is an easy-to-learn approach where participants are instructed to dissociate their attention from physical awareness, thoughts, and emotions by mentally slowly repeating a calming word or phrase (chosen by the participant themselves). SOS Meditation Instructions:
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Change in Generalize Anxiety Disorder Questionnaire Score
Tidsramme: Twice (Baseline and week 8 for arm 1 and week 8 and week 16 for arm 2)
|
Anxiety as measured using Generalize Anxiety Disorder Questionnaire |
Twice (Baseline and week 8 for arm 1 and week 8 and week 16 for arm 2)
|
|
Change in Pittsburgh Sleep Quality Index Questionnaire Score
Tidsramme: Twice (Baseline and week 8 for arm 1 and week 8 and week 16 for arm 2)
|
Sleep Quality measured using Pittsburgh sleep quality index (PSQI) |
Twice (Baseline and week 8 for arm 1 and week 8 and week 16 for arm 2)
|
|
Change in Mind Wandering Questionnaire Score
Tidsramme: Twice (Baseline and week 8 for arm 1 and week 8 and week 16 for arm 2)
|
Mind wandering measured using the Mind Wandering Questionnaire |
Twice (Baseline and week 8 for arm 1 and week 8 and week 16 for arm 2)
|
|
Resting Heart Rate
Tidsramme: Daily (from baseline to week 8 for arm 1 and from week 8 to week 16 for arm 2)
|
Daily obtained from Activity Tracker wrist band |
Daily (from baseline to week 8 for arm 1 and from week 8 to week 16 for arm 2)
|
|
Heart Rate Variability
Tidsramme: Daily (from baseline to week 8 for arm 1 and from week 8 to week 16 for arm 2)
|
Daily obtained from Activity Tracker wrist band |
Daily (from baseline to week 8 for arm 1 and from week 8 to week 16 for arm 2)
|
|
Change in Stroop Test Score
Tidsramme: Twice (Baseline and week 8 for arm 1 and week 8 and week 16 for arm 2)
|
Using the Stroop test, which measures the average reaction time between incongruent and congruent trials |
Twice (Baseline and week 8 for arm 1 and week 8 and week 16 for arm 2)
|
|
Change in N-back Test Score
Tidsramme: Twice (Baseline and week 8 for arm 1 and week 8 and week 16 for arm 2)
|
Using the N-back test is a memory task where participants must remember letters from N trials ago. |
Twice (Baseline and week 8 for arm 1 and week 8 and week 16 for arm 2)
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Change in Stress Scale Measure Questionnaire Score
Tidsramme: Twice (Baseline and week 8 for arm 1 and week 8 and week 16 for arm 2)
|
Stress measured using Perceived Stress Scale measure |
Twice (Baseline and week 8 for arm 1 and week 8 and week 16 for arm 2)
|
|
Change in Depression Questionnaire Score
Tidsramme: Twice (Baseline and week 8 for arm 1 and week 8 and week 16 for arm 2)
|
Depression measured using Patient Health Questionnaire |
Twice (Baseline and week 8 for arm 1 and week 8 and week 16 for arm 2)
|
|
Change in Quality of Life Scale Measures Questionnaire Score
Tidsramme: Twice (Baseline and week 8 for arm 1 and week 8 and week 16 for arm 2)
|
Quality of life measured using Quality of Life Scale measures |
Twice (Baseline and week 8 for arm 1 and week 8 and week 16 for arm 2)
|
|
Change Social Connectedness Scale-Revised Questionnaire Score
Tidsramme: Twice (Baseline and week 8 for arm 1 and week 8 and week 16 for arm 2)
|
Social Connectedness measured using Social Connectedness Scale-Revised |
Twice (Baseline and week 8 for arm 1 and week 8 and week 16 for arm 2)
|
|
Change in Rumination Reflection Questionnaire Score
Tidsramme: Twice (Baseline and week 8 for arm 1 and week 8 and week 16 for arm 2)
|
Rumination and reflection scales measured using Rumination Reflection Questionnaire |
Twice (Baseline and week 8 for arm 1 and week 8 and week 16 for arm 2)
|
|
Change in Brief Strengths Scale Questionnaire Score
Tidsramme: Twice (Baseline and week 8 for arm 1 and week 8 and week 16 for arm 2)
|
Strengths scale measured using Brief Strengths Scale measures individuals' Temperance Strength, Intellectual Strength, and Interpersonal Strength. |
Twice (Baseline and week 8 for arm 1 and week 8 and week 16 for arm 2)
|
|
Change in Sleep Quality Measure
Tidsramme: Daily (from baseline to week 8 for arm 1 and from week 8 to week 16 for arm 2)
|
Daily obtained from Activity Tracker wrist band |
Daily (from baseline to week 8 for arm 1 and from week 8 to week 16 for arm 2)
|
Samarbejdspartnere og efterforskere
Sponsor
Efterforskere
- Ledende efterforsker: Manish Saggar, PhD, Stanford University
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- 68784
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .